Seehra Jasbir
Insider CIK 1732369 · ELOX Director · KROS Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2026-04-02 | 2026-04-06 | 55,000 | — | $0 | 197,444 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2026-04-02 | 2026-04-06 | 55,000 | $0.30 | $16.5K | 440,708 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2026-02-24 | 2026-02-26 | 100,000 | — | $0 | 100,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2026-02-24 | 2026-02-26 | 217,000 | — | $0 | 217,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2026-02-19 | 2026-02-20 | 7,015 | $16.17 | $113.4K | 385,708 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2026-01-07 | 2026-01-09 | 62,500 | — | $0 | 62,500 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award | 2025-09-03 | 2025-09-05 | 90,500 | — | $0 | 392,723 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2025-04-04 | 2025-04-07 | 49,367 | — | $0 | 252,444 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2025-04-04 | 2025-04-07 | 49,367 | $0.30 | $14.8K | 302,223 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2024-02-23 | 2024-02-23 | 125,000 | — | $0 | 125,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2024-02-13 | 2024-02-15 | 125,000 | — | $0 | 125,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2023-04-08 | 2023-04-11 | 4,000 | — | $0 | 45,087 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2023-04-08 | 2023-04-11 | 4,000 | $0.48 | $1.9K | 252,856 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2023-02-16 | 2023-02-17 | 200,000 | — | $0 | 200,000 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | A Award deriv | 2022-06-15 | 2022-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2022-06-09 | 2022-06-10 | 5,000 | — | $0 | 8,822 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2022-06-09 | 2022-06-10 | 5,000 | $0.30 | $1.5K | 248,856 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2022-01-21 | 2022-01-25 | 165,000 | — | $0 | 165,000 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | A Award deriv | 2021-05-19 | 2021-05-20 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2021-01-10 | 2021-01-12 | 127,200 | — | $0 | 127,200 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | A Award deriv | 2020-05-20 | 2020-05-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | C Conversion deriv | 2020-04-13 | 2020-04-13 | 11,169 | — | $0 | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | P Buy | 2020-04-13 | 2020-04-13 | 20,000 | $16.00 | $320.0K | 243,856 | SEC↗ |
| KROS Keros Therapeutics, Inc. | C Conversion | 2020-04-13 | 2020-04-13 | 11,169 | — | $0 | 223,856 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2020-04-07 | 2020-04-08 | 696,569 | — | $0 | 696,569 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | A Award deriv | 2019-05-29 | 2019-05-29 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | A Award deriv | 2018-06-15 | 2018-06-19 | 40,000 | — | $0 | 40,000 | SEC↗ |